Evidence map›Paper›PMID 40296900›Full record

ArticleOncology research2025

The alternatively spliced diacylglycerol kinase gamma-Δ exon13 transcript generated under hypoxia promotes glioblastoma progression.

Ming Yang, Liangzhao Chu, Shukai Lin, Han Peng, Niya Long, Kaya Xu, Hua Yang, Feng Han, Jian Liu

Abstract read
In one paragraph

Article in Oncology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ming YangDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Liangzhao ChuDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Shukai LinDepartment of Neurosurgery, Sanya Central Hospital (Hainan Third People's Hospital), Sanya, 572000, China.
Han PengDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Niya LongDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Kaya XuDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Hua YangDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Feng HanDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
Jian LiuDepartment of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glioblastoma (GBM) is one of the most malignant types of central nervous system tumors. Oxygen deprivation in the tumor microenvironment is thought to be an important factor in promoting GBM progression. However, the mechanisms of hypoxia-promoted tumor progression remain elusive. Methods: Alternative splicing of diacylglycerol kinase gamma (DGKG)-Δ exon13 was amplified and verified by PCR-Sanger sequencing. The functions of DGKG and DGKG-Δ exon13 were analyzed by Cell counting kit-8 (CCK-8), Transwell, Matrigel-transwell experiments, and Results: In this study, we found that a new transcript DGKG-Δ exon13 was generated in GBM under hypoxia via alternative splicing. Moreover, the results of CCK-8, Transwell, and Matrigel-transwell experiments showed that the proliferation, migration, and invasion abilities of U87-MG and T98G were decreased after DGKG knockdown. Compared to wild-type DGKG, DGKG-Δ exon13 overexpression significantly promoted cellular proliferation, migration, and invasion abilities in GBM. Furthermore, Conclusions: Our study found that hypoxia-induced alternative splicing transcript DGKG-Δ exon13 promotes GBM proliferation and infiltration, which might provide a new potential target for the clinical treatment and diagnosis of GBM.

Indexed as

Alternative SplicingBrain NeoplasmsDiacylglycerol KinaseExonsGlioblastomaAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticHumansMiceMice, NudeTumor MicroenvironmentDiacylglycerol KinaseAlternative splicingDiacylglycerol kinase gamma (DGKG)Glioblastoma (GBM)Hypoxia

Identifiers

PMID40296900
PMCPMC12034013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.